Manus is a drug discovery company that raised over $50 million through a couple of seed rounds last year. The startup is making progress on 'Move 37' AI, meaning AI that supersedes human creativity in chemistry, especially to combat various cancers.
Structure & People
Corporate Family
Manus
People3 people
Reid HoffmanCo-Founder, Chairman of the Board
Ujjwal SinghCo-Founder and Chief Technology Officer
